Subscribe To
ANL / U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline
ANL News
By Seeking Alpha
September 30, 2023
U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline
The third quarter wrapped up with four IPOs and eight pipeline additions. Eight issuers submitted initial filings this past week. The October IPO mark more_horizontal
By Seeking Alpha
August 12, 2023
U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices
Three small issuers began trading this past week, two of which were eligible for inclusion in our IPO stats. While most IPOs are biding their time thr more_horizontal
By Seeking Alpha
August 11, 2023
IPO Update: Adlai Nortye Readies $72 Million U.S. IPO
Adlai Nortye Ltd. has filed for a $72 million IPO for its cancer drug development. The firm's lead candidate, AN2025, is in Phase 2 and Phase 3 trials more_horizontal
By Market Watch
August 11, 2023
Cancer treatment company Adlai Nortye sets terms in IPO
Adlai Nortye Ltd. said late Thursday it plans to offer three million American depositary shares at an estimated price of $22 to $26 a share in its ini more_horizontal